ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹576 Cr | ₹452 Cr | ₹373 Cr | ₹315 Cr | ₹215 Cr |
What is the latest Net Current Assets ratio of ASTRAZENECA PHARMA INDIA ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹576 Cr |
Mar2023 | ₹452 Cr |
Mar2022 | ₹373 Cr |
Mar2021 | ₹315 Cr |
Mar2020 | ₹215 Cr |
How is Net Current Assets of ASTRAZENECA PHARMA INDIA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹576 Cr | 27.47 | |
Mar2023 | ₹452 Cr | 21.05 | |
Mar2022 | ₹373 Cr | 18.32 | |
Mar2021 | ₹315 Cr | 46.58 | |
Mar2020 | ₹215 Cr | - |
Compare Net Current Assets of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹16,829.9 Cr | -4.9% | 1.9% | 11.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹421,527.0 Cr | -3.8% | -3% | 34.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,037.0 Cr | 0.9% | 0.4% | 53.5% | Stock Analytics | |
CIPLA | ₹116,854.0 Cr | -2.8% | -0.1% | 9.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,746.0 Cr | -2.4% | 5.5% | 17.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,093.9 Cr | -2.4% | -0.3% | 42.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -4.9% |
1.9% |
11.7% |
SENSEX | -1.8% |
-6.6% |
7.1% |
You may also like the below Video Courses